TFF Pharmaceuticals Inc
F:0K3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
TFF Pharmaceuticals Inc
F:0K3
|
US |
|
A
|
Aethlon Medical Inc
F:EJU
|
US |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
S
|
Seek Ltd
F:SLD
|
AU |
|
L
|
LEG Immobilien SE
DUS:LEG
|
DE |
|
Rural Funds Group
F:J19
|
AU |
|
T
|
Telo Genomics Corp
OTC:TDSGF
|
CA |
|
F
|
Figma Inc
NYSE:FIG
|
US |
|
Rossari Biotech Ltd
BSE:543213
|
IN |
|
P/F Bakkafrost
F:6BF
|
FO |
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
HTC Corp
F:HTJ
|
TW |
|
V
|
Verizon Communications Inc
XMUN:BAC
|
US |
|
B
|
Burlington Stores Inc
BMV:BURL
|
US |
|
K
|
Krakatau Steel (Persero) Tbk PT
XMUN:07K
|
ID |
|
G
|
Graham Holdings Co
F:WPOB
|
US |
|
A
|
Adidas AG
XHAM:ADS
|
DE |
|
Straumann Holding AG
F:QS50
|
CH |
|
Sanofi India Ltd
BSE:500674
|
IN |
|
clearvise AG
F:ABO
|
DE |
|
M
|
Metcash Ltd
F:MG9
|
AU |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XMUN:SLL
|
AT |
|
StepStone Group Inc
NASDAQ:STEP
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0K3's stock price target?
Not Available
0K3 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for TFF Pharmaceuticals Inc?
Projected CAGR
154%
The compound annual growth rate for Revenue over the next 3 years is 154%.